In bacterial systems, CRISPR-Cas transcriptional activation (CRISPRa) has the potential to dramatically expand our ability to regulate gene expression, but we currently lack a complete understanding of the rules for designing effective guide RNA target sites. We have identified multiple features of bacterial promoters that impose stringent requirements on bacterial CRISPRa target sites. Most importantly, we found that shifting a gRNA target site by 2-4 bases along the DNA target can cause a nearly complete loss in activity. The loss in activity can be rescued by shifting the target site 10-11 bases, corresponding to one full helical turn. Practically, our results suggest that it will be challenging to find a gRNA target site with an appropriate PAM sequence at precisely the right position at arbitrary genes of interest. To overcome this limitation, we demonstrate that a dCas9 variant with expanded PAM specificity allows activation of promoters that cannot be activated by S. pyogenes dCas9. These results provide a roadmap for future engineering efforts to further expand and generalize the scope of bacterial CRISPRa.
Introduction
Developing tools to activate the expression of arbitrary genes has been transformative for biotechnology and biological research 1 . In metabolic engineering, regulating the timing and levels of the expression of complex multi-gene pathways is critical for reducing cellular burden and improving production of valuable metabolites 2 . To enable these goals, we recently developed a new CRISPR-Cas transcriptional activation (CRISPRa) system that is effective in E. coli. Our system can be combined with CRISPRi gene repression to programmably and flexibly target multiple genes for simultaneous activation and repression 3 . While our CRISPRa system can be used with heterologous genes, an outstanding challenge is to understand the rules that define effective target sites at arbitrary promoters in the genome.
To programmably target genes, we use nuclease defective Cas9 (dCas9) with a guide RNA (gRNA) that specifies a target site on the DNA. Targeting this complex to a promoter or an open reading frame (ORF) results in gene repression (CRISPRi) 4 . To enable simultaneous activation, we use modified guide RNAs, termed scaffold RNAs (scRNAs), that include a 3' MS2 hairpin to recruit a transcriptional activator fused to the MS2 coat protein (MCP) 3 . We can express multiple gRNAs and scRNAs to inhibit and activate genes simultaneously; gRNAs targeted to a promoter or ORF result in CRISPRi and scRNAs targeted to an appropriate site upstream of a minimal promoter result in CRISPRa.
We demonstrate here that the rules for targeting CRISPRa to effective sites in E. coli are surprisingly stringent. In prior work, we found that CRISPRa in E. coli was effective at target sites located in a narrow 40 base window between 60 and 100 bases upstream of the transcriptional start site (TSS) 3 . Here, we show that multiple factors combine to make the requirements for effective sites even more strict. We demonstrate that the basal promoter strength of the target gene and the sequence composition between the target site and the minimal promoter can have dramatic effects on gene activation. Further, by scanning the 40 base window at single base 3 resolution, we find sharp peaks of activity and broad regions of inactivity that occur in a periodic 10-11 base pattern, corresponding to one helical turn along the DNA target. The observation that only a few precisely-positioned target sites upstream of the TSS are effective for CRISPRa poses a significant challenge, as many genes will likely lack an NGG PAM sequence at exactly the right position necessary for S. pyogenes dCas9. These stringent requirements may explain why CRISPRa and other tools for gene activation in bacteria have lagged far behind comparable tools in eukaryotic systems, where such strict target site requirements are absent 5 .
Although the requirements for bacterial CRISPRa target sites pose challenges, our data also demonstrate CRISPRa has the potential to be effective at a broad range of target genes. In addition to σ 70 -dependent genes, CRISPRa can activate expression from genes that use the σ 70 family members σ 38 , σ 32 , and σ 24 , which covers a broad range of the E. coli genome 6 . We further demonstrate that the strict requirement for a precisely positioned PAM site can be partially overcome using a re-engineered dCas9 protein that targets an expanded set of PAM sequences 7 .
Similar results were recently reported for an alternative bacterial CRISPRa system that can target genes regulated by σ 54 promoters 8 , which were not activated by our system. The availability of these complementary systems should further extend the scope of bacterial CRISPRa. More broadly, by systematically defining the rules for effective CRISPRa sites, we have identified new strategies for improving and generalizing synthetic gene regulation in bacteria.
Results

A SoxS double mutant reduces off-target activation of endogenous SoxS-responsive promoters
Ideally, a synthetic transcriptional activator should only activate its programmed target genes. The activation domain for our CRISPRa system is SoxS, a native E. coli transcription factor that directly binds DNA and activates endogenous gene targets as part of a stress response program 3 . We previously demonstrated that point mutations in the SoxS DNA binding site can reduce activation of endogenous SoxS targets while maintaining CRISPRa activity at a heterologous reporter gene. However, the most effective single point mutants, R93A and S101A, did not completely abolish activity at endogenous targets. To further minimize off-target SoxS activity, we tested a double mutant SoxS(R93A/S101A). This double mutant SoxS retained full CRISPRa activity and showed a reduction in endogenous SoxS-dependent gene expression to levels indistinguishable from background ( Figure 1 ). Thus, SoxS(R93A/S101A) is an effective modular transcriptional effector that can activate gene expression only when recruited to a target gene via the CRISPR-Cas complex.
A simple distance-based metric for target site selection is not sufficient for effective CRISPRa at endogenous gene targets
To determine if we could predictably activate endogenous genes with CRISPRa, we selected three candidate genes with appropriately positioned PAM sites upstream of the TSS.
Previously, we demonstrated that CRISPRa can activate heterologous promoters with target sites positioned within a 40 base window between 60 and 100 bases upstream of the transcriptional start site (TSS) 3 . We therefore targeted the CRISPR-Cas complex to the same window upstream of the candidate target genes. First, we targeted the aroK-aroB operon, which expresses enzymes involved in aromatic amino acid biosynthesis, whose programmed overexpression could be useful for bioproduction 9 . Targeting the CRISPR-Cas complex to two sites within the optimal 40 base window resulted in up to 5-fold increases in expression, but these effects were highly variable between replicates and most were far smaller. Further, sites inside and outside of the 40 base window gave similar effects ( Figure 2A ). Next, we targeted cysK, an enzyme involved in cysteine biosynthesis 10 . Similar to what we observed with aroK-aroB, targeting a site positioned at -93 from the TSS resulted in expression levels that were highly variable between replicates, ranging from 2.4-fold to 0.8-fold compared to a control expressing an off-target scRNA ( Figure 2B ). Targeting two other sites within the 40 base window, at -79 and -61, resulted in similarly variable and, in some cases, decreasing levels of expression. Finally, we targeted ldhA, an enzyme involved in 5 mixed acid fermentation 11 . We selected 8 sites and observed small increases in gene expression up to 1.5-fold, with no apparent relationship between the position of the target site and ldhA expression ( Supplementary Figure 1 ). Together, these results suggest that endogenous genes cannot be activated simply by targeting the CRISPR-Cas complex to sites positioned between 60 and 100 bases upstream of the TSS. The levels of activation we achieved were modest compared to the 50-fold effects seen by RT-qPCR at heterologous promoters 3 . Even for sites that had modest effects, their positions did not correspond to the predicted optimal sites based on the results from heterologous promoters.
There are several possible explanations for our inability to activate endogenous bacterial genes with CRISPRa. First, we originally demonstrated CRISPRa using a relatively weak synthetic promoter. The basal levels of expression of endogenous genes vary significantly 12 , and it may be difficult to increase the transcription of genes that are already strongly expressed 13 . In addition, some endogenous target genes might require an alternative sigma factor. Our original reporter gene is controlled by the σ 70 housekeeping sigma factor, and we do not know if our
CRISPRa system is effective at gene targets that use alternative sigma factors. Another possibility is that native transcriptional regulator binding sites near endogenous gene promoters could disrupt CRISPRa. Finally, the optimal distance window metric that we previously identified may have been oversimplified. We initially identified the optimal window from an experiment with target sites spaced 10 bases apart, which may not be sufficient to generalize to any site within the 40 base window. To systematically explore these possibilities, we proceeded to test the efficacy of CRISPRa is sensitive to promoter strength
To evaluate whether the intrinsic strength of the promoter affects CRISPRa, we tested activation on a set of fluorescent reporter genes with minimal promoters spanning a 200-fold 6 range in basal expression level (http://parts.igem.org) ( Figure 3A ). We observed the most effective gene activation with a moderately weak J23117 promoter. With the weakest promoters, we could not detect any activation, even though their basal expression levels were only 2-fold weaker than the J23117 promoter. With stronger promoters, we observed progressively smaller CRISPRa-mediated activation of gene expression; the basal expression level increased, while the maximal, CRISPRa-induced expression remained roughly constant. These results indicate that the bacterial CRISPRa activity varies considerably with promoter strength, similar to effects observed in eukaryotic systems 14, 15 . Thus, when targeting arbitrary endogenous genes, the level of activation that can be achieved may depend on the basal level of expression of its promoter.
CRISPRa is effective with alternative sigma factors
Bacterial transcription is initiated by a sigma factor binding to the minimal promoter and the RNA polymerase holoenzyme 16 .The SoxS activator binds directly to the α subunit of RNA polymerase 17 , which suggests that our CRISPRa system could be compatible with genes that are controlled by non-housekeeping sigma factors. To investigate this possibility, we built synthetic promoters regulated by σ 38 (RpoS), σ 32 (RpoH), σ 24 (RpoE), and σ 54 (RpoN) to compare with our original housekeeping σ 70 (RpoD) promoter ( Figure 3B ) [18] [19] [20] [21] . CRISPRa was able to activate reporter gene expression when we targeted sites between -60 and -100 upstream of σ 38 , σ 32 , and σ 24 -dependent promoters; these σ factors are all members of the σ 70 family. CRISPRa was not active on the σ 54 promoter, possibly because σ 54 initiates gene expression using a distinct mechanism that requires additional cis-regulatory elements 16 . Activation with promoters regulated by alternative sigma factors was significantly lower than the activation we obtained with a σ 70dependent promoter. Therefore, while activity will depend on the specific characteristics of the target promoter, in principle CRISPRa can activate promoters regulated by non-housekeeping sigma factors such as σ 38 , σ 32 , and σ 24 , and likely other members of the homologous σ 70 family.
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A recent paper described an alternative CRISPRa system that is capable of activating σ 54dependent genes, which is complementary to our system 8 .
CRISPRa is sensitive to intervening sequence composition Our initial model for effective CRISPRa target sites considered the distance of the target site from the TSS but ignored the composition of the intervening sequence upstream of the -35 region. To determine if these sequences affect CRISPRa, we constructed a pooled library of synthetic promoters with randomized sequences between the scRNA target site and the -35
region. We observed a broad distribution of gene activation over a 27-fold range, even though each sequence in this library contained the same scRNA target site and the same minimal promoter ( Figure 3C ). One possible interpretation of this result is that these randomized sequences contain binding sites for endogenous transcriptional regulators; there is evidence that binding sites can emerge with relatively high frequency from random sequences 22 . These sites could potentially affect the efficacy of CRISPRa by directly blocking access to a scRNA target site, by blocking RNA polymerase binding, or by interfering with the ability of a CRISPRa effector protein to engage with RNA polymerase.
To directly test the hypothesis that a bound transcriptional effector can disrupt CRISPRa, we introduced a binding site for the transcriptional repressor TetR upstream of the -35 region 23 .
The presence of a bound TetR significantly disrupted CRISPRa-mediated gene activation.
Further, adding anhydrotetracycline (aTc), which releases TetR from the DNA, restored CRISPRa activity to the levels observed when TetR was not present ( Figure 3D ). Taken together, these experiments suggest that the composition of the intervening sequence between the CRISPR-Cas complex and the minimal promoter has a significant effect on the efficacy of CRISPRa, possibly due to the presence of protein binding sites. Because endogenous genes contain binding sites for a variety of transcriptional activators and repressors upstream of the minimal promoter 24,25 , 8 this effect could be contributing to the inconsistent and variable effects we observed when targeting endogenous genes for CRISPRa ( Figure 2 ).
CRISPRa is sharply dependent on single base shifts in target site position
Our original hypothesis that optimal target sites are located -60 to -100 bases upstream of the TSS was based on an experiment with scRNA sites spaced every 10 bases 3 . To further test this hypothesis, we targeted the CRISPRa complex to a window from -61 to -113 at single base resolution. We used a reporter gene with 5 scRNA sites located at -61, -71, -81, -91, and -101 relative to the TSS, and we inserted 1-12 bases upstream of the -35 site to generate a set of reporter genes that allowed the CRISPRa complex to target every possible distance in the optimal targeting window. Using this reporter gene set, we found that shifting the target site by 1-3 bases caused significant decreases in activation ( Figure 4A ). Shifting the target site further by 4-9 bases decreased expression to levels nearly indistinguishable from background. At 10-11 base shifts, corresponding to one full turn of a DNA helix, gene expression increased again. This periodic positional dependence of CRISPRa extended over the entire -60 to -100 window, with the strongest peaks centered at -81 and -91 and smaller peaks centered at -102 and -70. There is no recovery of activity when the site at -101 is shifted to -111, outside of the -60 to -100 window. This sharp periodic relationship suggests that the criteria for effective target sites are quite stringent, and that both distance and relative periodicity to the TSS are critical factors.
Notably, the distance to the TSS is not the sole determining factor for CRISPRa-mediated expression level. Sites that overlap at the same distance, such as the original -81 site and the -71 site shifted by 10, do not give the same gene expression output ( Figure 4A ). These discrepancies could arise from intrinsic differences in the activity of the 20 base scRNA target sequence (Supplementary Figure 2 ) or from the effect of different intervening sequence composition between the scRNA target site and the minimal promoter ( Figure 3 ).
Because we demonstrated that sequence composition can have unexpected effects on CRISPRa (Figure 3 ), we tested whether the periodicity of CRISPRa was similar in different sequence contexts. We obtained a comparable periodic phase dependence when different nucleotide sequences were used to shift the scRNA target site, and when the bases were inserted at a different location in the promoter (Supplementary Figure 3A) . Similar results were also obtained when we performed the base shift experiment with a reporter that had a different 5'
upstream sequence (Supplementary Figure 3B) or where the minimal BBa_J23117 promoter was replaced by endogenous aroK promoter (Supplementary Figure 3C) . Further, the sharp positioning dependence was observed when targeting the template or non-template strand of the reporter (Supplementary Figure 3D ). Finally, one possible confounding effect could arise if the basal expression level of the reporter gene changes when bases are inserted, which can affect the efficacy of CRISPRa ( Figure 3A ). However, we observed that basal expression from the original reporter and the +5 base shifted reporter were indistinguishable (Supplementary Figure   3E ). Together, these experiments confirm that bacterial CRISPRa is sensitive to periodicity in multiple different sequence contexts.
In the experiments described above, comparisons between single base shifted scRNA sites were performed with different reporter gene constructs, each with a differing number of inserted bases. To test the positional dependence of CRISPRa at single base resolution in a single reporter construct, we designed an alternative reporter gene with 6 adjacent scRNA target sites between -81 and -86. We again observed sharp drops in gene expression when targeting sites one or more bases away from the optimal site at -81 (Supplementary Figure 3F ).
The finding that CRISPRa displays the same ~10 base periodicity as the DNA helix suggests that the angular phase of the CRISPRa complex relative to the minimal promoter is critical for effective activation. Our bacterial CRISPRa system requires a direct interaction between the SoxS activation domain and RNA polymerase 3 , and this interaction appears to be highly sensitive to both the distance and relative phase of the target site to the minimal promoter.
Effective target sites must be located not only at the proper distance, but also at one of the narrow peaks of activation within the optimal distance range. These stringent requirements suggest that targeting endogenous genes will be extremely challenging. There is ~1 PAM site every 10 bases in the regions upstream of endogenous promoters in E. coli (Supplementary Figure 4) , and the likelihood that a PAM site will be located at the appropriate phase within a 10 base window is low (Supplementary Figure 4C ).
Modifying the CRISPRa complex structure does not expand the range of effective target sites If rotating the CRISPRa complex out of phase along the DNA prevents SoxS from interacting with RNA polymerase, then a longer amino acid linker to SoxS might allow effective CRISPRa at more scRNA sites. To test this possibility, we extended the linker between MCP and SoxS from 5 amino acids (aa) to 10 or 20 aa, but even with these longer linkers we observed the same sharp dependence on the target site position as with the original 5 aa linker ( Figure 4B ).
We obtained similar results using a linker with a different amino acid composition (Supplementary Figure 5A ).
Another potential approach to expand the range of effective CRISPRa sites would be to change the spatial position of the MCP-SoxS protein by altering the position of the MS2 hairpin that binds MCP. We therefore tested multiple alternative scRNA designs that present the MS2 hairpin at different locations. Extending the MS2 stem by 2, 5, 10, and 20 bp resulted in progressively lower CRISPRa activity, but no change in the position of the target sites that were most effective (Supplementary Figure 5B) . Similarly, no changes were observed with alternative scRNA designs with one or two MS2 hairpins presented from different locations within the scRNA structure (Supplementary Figure 5C ).
Finally, we assessed whether any alternative activation domains could produce a different phase dependent behavior. Previously, these constructs all produced weaker activation than SoxS 3 , perhaps because they have each distinct optimal target site positions. We tested MCP 11 fused to TetD, αNTD, lambda cII, and RpoZ 3 , and dCas9 fused to RpoZ 26 ; however, none of these constructs produced gene activation at any site that was not already effective with SoxS ( Supplementary Figure 6 ).
The sharp phase dependence of CRISPRa may be a general feature of transcriptional regulation in E. coli. The native SoxS protein and other transcription factors such as CAP and
LacI have restrictive positioning requirements that correspond to DNA periodicity [27] [28] [29] ; we confirmed this result with an endogenous SoxS reporter ( Supplementary Figure 7) . It remains surprising that no structural modifications of the CRISPRa complex produced any changes in the phase dependence. If SoxS is simply tethered to the CRISPRa complex by a flexible linker, we would have expected the peak of effective CRISPRa sites to broaden with longer linkers. The failure of this prediction suggests that our understanding of the CRISPR-Cas complex and its interactions with bacterial transcriptional machinery is fundamentally incomplete, or that the linker tethering SoxS to the CRISPRa complex is not truly flexible. Practically, it means that we still lack a way to expand the range of effective CRISPRa target sites.
An expanded PAM dCas9 variant expands the scope of targetable CRISPRa sites
Because there is a limited number of genes with an appropriate NGG PAM site at precisely the optimal position upstream of the promoter (Supplementary Figure 4C) , we attempted to expand the scope of targetable PAM sites for CRISPRa. We used a recently characterized dCas9 variant, dxCas9(3.7), that has improved activity at a variety of non-NGG PAM sites including NGN, GAA, GAT, and CAA 7 . We generated reporter plasmids by replacing AGG PAM sites with alternative PAM sequences and delivered a CRISPRa system with dxCas9(3.7) to target these reporters. dxCas9(3.7) maintained the ability to target the AGG PAM and showed significantly increased levels of activation at alternative PAM sites compared to dCas9 ( Figure 5A ). Activation levels varied with different PAM sites and correlated well with dxCas9(3.7) activity previously reported in human cells (Supplementary Figure 8A Figure 8D) . Accounting for the fact that dCas9 has some activity at non-NGG sites 7 (Figure 5A ), there are still on average ~2.2-fold more dxCas9(3.7)-compatible PAM sites than dCas9-compatible PAM sites (Supplementary Figure 8D) .
To demonstrate the utility of dxCas9(3.7) for CRISPRa at sites inaccessible to dCas9, we constructed a reporter plasmid that contains an AGG PAM site at the original position with maximum CRISPRa activity and an AGT PAM 5 bases downstream. Using this reporter, we observe that both dCas9 and dxCas9(3.7) are effective for CRISPRa at the optimally-positioned NGG PAM site, but neither is capable of activating the AGT PAM site, which is 5 bases out of phase from the optimal site ( Figure 5B ). We then inserted 5 bases into the reporter to shift the AGT PAM site into the peak activation range. With this reporter, neither dCas9 nor dxCas9(3.7)
can activate the NGG PAM site, which is now out of phase. dxCas9(3.7) was now able to effectively activate the AGT PAM site, and dCas9 was ineffective at this site ( Figure 5B ). This result confirms that dxCas9(3.7) is able to activate optimally-positioned target sites that are inaccessible to dCas9. We expect that this behavior will be effective at many σ 70 -family promoters ( Figure 3B) , and a recent report demonstrated a similar behavior of dxCas9(3.7) at σ 54 -dependent promoters 8 .
Defined rules for effective CRISPRa enable endogenous gene activation
Our systematic characterization of the requirements for effective CRISPRa in E. coli demonstrates that candidate genes must have a targetable PAM site located at one of the sharp peaks of activity upstream of the TSS. In hindsight, the scRNA sites at endogenous genes that we initially targeted in Figure 2 did note meet this criterion. To determine if the revised rules would 13 enable activation of endogenous E. coli genes, we surveyed the genome for candidate genes with appropriately positioned, dxCas9(3.7)-compatible PAM sites (Supplementary Methods) (Supplementary Figure 4C) . We selected candidates with multiple potentially effective PAM sites and further narrowed the pool based on two additional criteria: (1) genes should not be too highly expressed ( Figure 3A) and (2) genes should be regulated by σ 70 , which was the sigma factor that produced the strongest activation ( Figure 3B ). Ideally, we would also exclude genes with tightly bound transcriptional regulators in the promoter region ( Figure 3D ), but this information is not readily available. We chose six genes that could be tested using flourescent reporter strains from the E. coli promoter collection 30 and targeted two PAM sites for each gene.
We first examined the yajG gene, which had two plausible target sites, one of which was only compatible with dxCas9(3.7). We also included an additional site predicted to be out of phase and ineffective for CRISPRa. We observed significant, ~4-6-fold gene activation for the two sites located at the predicted peak of activity at -80/-81, and no activation at the out of phase site at -87 ( Figure 6A ). The site at -81 is inaccessible to dCas9, and we only observed activation with dxCas9(3.7). We proceeded to test an additional five genes with partial success. We observed significant activation at three genes, although the effects were closer to ~2-fold ( Figure 6B ). We validated these results by performing RT-qPCR on the endogenous yajG and poxB loci; the better performing site for each gene resulted in increases in RNA levels ( Supplementary Figure 9 ). For the remaining two candidate genes, there was no detectable activation. Similarly, one of the ldhA sites that we targeted in initial experiments ( Supplementary Figure 1) was at a predicted optimal site at -91 and failed to give substantial activation.
Although any success at endogenous gene activation is encouraging, significant challenges remain for predictable CRISPRa in bacteria. Our results suggest that even with a precise distance metric for effective target sites, some genes will not be predictably activated.
There are several possible explanations: (1) tightly bound negative regulators could interfere with CRISPRa ( Figure 3D) , and (2) small errors in transcription start site annotation could lead to inaccurate predictions for effective sites, given that 1-2 base shifts can have dramatic effects on CRISPRa (Figure 4) , and (3) intrinsic differences in the activity of the 20 base scRNA target sequence ( Supplementary Figure 2) .
Discussion
Bacterial CRISPRa is sensitive to a number of factors, including (i) the strength of the target promoter, (ii) the sigma factor regulating the promoter, (iii) the sequence composition immediately upstream of the minimal promoter, (iv) the composition of the scRNA target sequence, (v) the position of the scRNA target site with respect to the TSS at single base resolution. Some of these factors, such as promoter strength and scRNA target sequence composition, are also relevant in eukaryotic systems 13, 15, 31, 32 . Other factors are plausible given our understanding of bacterial transcription. Sigma factor levels are regulated to control gene expression in response to cell state and external signals 16 , so it is reasonable that we observed variable levels of activation from promoters with alternative sigma factors. Many bacterial genes are controlled by negative regulators 33 , and different sequences upstream of the minimal promoter could be recruiting repressors.
The most unexpected property that we observed with bacterial CRISPRa was its sharp, periodic dependence on target site position. This behavior is quite distinct from CRISPRa in eukaryotes, where a broad range of sites upstream of the TSS are effective 34 , possibly because eukaryotic activators typically recruit transcription factors and chromatin modifying machinery rather than directly recruiting RNA polymerase. There is precedent for bacterial transcriptional activators that are sensitive to target site periodicity [27] [28] [29] , but the dramatic changes in activity with only single base shifts is surprising. Moreover, it is puzzling that we were unable to predictably alter or broaden the range of sites that are effective. Our models for how activators interact with bacterial transcription machinery may be incomplete. It will likely be productive to continue screening for activity at out-of-phase target sites using additional systematic modifications to the CRISPRa complex structure, alternative CRISPR-Cas systems, and additional candidate transcriptional activation domains.
Despite the challenges described above for identifying effective CRISPRa sites in E. coli, our systematic characterization provides a framework for immediate practical applications and a path for future improvements. We now have a clear understanding of the criteria needed to design synthetic promoters that can be regulated by CRISPRa, which will enable the construction of complex, tunable synthetic multi-gene circuits. To extend the scope of CRISPRa to endogenous target genes, expanded PAM variants like dxCas9(3.7) 7 , or orthologous dCas9 proteins with alternate PAM specificities 35, 36 will open more DNA sites for targeting, increasing the likelihood of finding a targetable site at an optimal position relative to the TSS. These strategies lay the groundwork for more widespread use of bacterial CRISPRa in basic research and practical applications including functional genomics screens, metabolic engineering, and synthetic microbial communities.
Methods
Bacterial Strain Construction and Manipulation
Plasmids were cloned using standard molecular biology protocols. Bacterial strains with sfGFP or mRFP1 reporter strains are described in Supplementary Table 1 . The CRISPRa system used for each figure panel is described in Supplementary Table 2 . Guide RNA target sequences are described in Supplementary Table 3 . Plasmid containing the reporter genes and the CRISPR components are described in Supplementary Table 4 . Supplementary Table 5 .
Expression levels for each gene were calculated by normalizing to the 16S rRNA gene and relative to a negative control carrying an off target-scRNA using the ΔΔCT method 37 . 
